<VariationArchive VariationID="2969924" VariationName="NM_016204.4(GDF2):c.857dup (p.Leu287fs)" VariationType="Duplication" Accession="VCV002969924" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3129015" VariationID="2969924">
      <GeneList>
        <Gene Symbol="GDF2" FullName="growth differentiation factor 2" GeneID="2658" HGNC_ID="HGNC:4217" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="47322454" stop="47327588" display_start="47322454" display_stop="47327588" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="48413091" stop="48416852" display_start="48413091" display_stop="48416852" Strand="-" />
          </Location>
          <OMIM>605120</OMIM>
          <Haploinsufficiency last_evaluated="2016-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDF2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDF2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_016204.4(GDF2):c.857dup (p.Leu287fs)</Name>
      <CanonicalSPDI>NC_000010.11:47325349:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="47325349" stop="47325350" display_start="47325349" display_stop="47325350" variantLength="1" positionVCF="47325349" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="48414010" stop="48414011" display_start="48414010" display_stop="48414011" variantLength="1" positionVCF="48414010" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>L287fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.48414012dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.48414012dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.47325351dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.47325351dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033916.1" sequenceAccession="NG_033916" sequenceVersion="1" change="g.7862dup">
            <Expression>NG_033916.1:g.7862dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016204.4" sequenceAccession="NM_016204" sequenceVersion="4" change="c.857dup" MANESelect="true">
            <Expression>NM_016204.4:c.857dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057288.1" sequenceAccession="NP_057288" sequenceVersion="1" change="p.Leu287fs">
            <Expression>NP_057288.1:p.Leu287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016204.4(GDF2):c.857dup (p.Leu287fs) AND Telangiectasia, hereditary hemorrhagic, type 5" Accession="RCV003822058" Version="1">
        <ClassifiedConditionList TraitSetID="12093">
          <ClassifiedCondition DB="MedGen" ID="C3809710">Telangiectasia, hereditary hemorrhagic, type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30578397</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31727138</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35346192</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12093" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18351" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Telangiectasia, hereditary hemorrhagic, type 5</ElementValue>
                <XRef ID="MONDO:0014217" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT5</ElementValue>
                <XRef Type="MIM" ID="615506" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15978" />
                <XRef ID="15978" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C3809710" DB="MedGen" />
              <XRef ID="MONDO:0014217" DB="MONDO" />
              <XRef Type="MIM" ID="615506" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8583760" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="10357177|MedGen:C3809710" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004627647" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30578397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31727138</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31727138</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35346192</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GDF2 protein in which other variant(s) (p.Val423Met) have been determined to be pathogenic (PMID: 30578397, 31727138). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individuals with autosomal dominant pulmonary arterial hypertension (PMID: 31727138, 35346192; Invitae). This sequence change creates a premature translational stop signal (p.Leu287Alafs*11) in the GDF2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 143 amino acid(s) of the GDF2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GDF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.48414010_48414011insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3809710" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8583760" TraitType="Disease" MappingType="XRef" MappingValue="C3809710" MappingRef="MedGen">
        <MedGen CUI="C3809710" Name="Telangiectasia, hereditary hemorrhagic, type 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

